This bill matters because it directly impacts the financial stability of many healthcare providers that serve vulnerable populations and the affordability of prescription drugs for their patients. The 340B program allows eligible hospitals and clinics to buy drugs at a discount, using the savings to fund critical services like reduced-cost care, transportation, or expanded health programs. In recent years, some drug manufacturers have stopped providing these discounts when covered entities use contract pharmacies, arguing that they lack visibility into how the drugs are used. This has created a significant financial strain on these providers.

If this bill becomes law, it would legally prevent manufacturers from imposing such restrictions, preserving the ability of covered entities to use contract pharmacies and maintain their savings. This means more resources for patient care in underserved communities and potentially lower drug costs for patients. If it doesn't pass, healthcare providers may continue to face restrictions, leading to reduced savings, potentially fewer services, and higher drug costs for their patients, especially for expensive specialty medications.